1. Antituberculars: paradoxical reactions require revision of precautions

   News item 06 May 2023 Pages: 1 - 1

2. Canadian product monograph for ella updated

   News item 06 May 2023 Pages: 2 - 2

3. Clopidogrel increases rosuvastatin exposure

   News item 06 May 2023 Pages: 3 - 3

4. Fingolimod-associated bradycardia

   News item 06 May 2023 Pages: 4 - 4

5. Nitrofurantoin-related risks of pulmonary and hepatic ADRs

   News item 06 May 2023 Pages: 5 - 5

6. Permethrin-related skin disorders

   News item 06 May 2023 Pages: 6 - 6

7. Recommendations to strengthen safety of isotretinoin

   News item 06 May 2023 Pages: 7 - 7

8. Singaporean HSA advises against use of two herbal medicines

   News item 06 May 2023 Pages: 8 - 8

9. Viral vector-based COVID-19 vaccines: risk of thrombosis with thrombocytopenia

   News item 06 May 2023 Pages: 9 - 9

10. COVID-19 vaccine in adolescents: no new serious safety concerns identified

    Clinical study 06 May 2023 Pages: 10 - 10

11. COVID-19 vaccine-related ADRs in children and adolescents

    Clinical study 06 May 2023 Pages: 11 - 11

12. Effects of pregabalin exposure on risk of fetal death and congenital abnormalities

    Clinical study 06 May 2023 Pages: 12 - 12

13. Pulmonary haemorrhage due to thoracic radiotherapy and VEGFi

    Clinical study 06 May 2023 Pages: 13 - 13

14. Other adverse reaction research

    News item 06 May 2023 Pages: 14 - 14

15. Abatacept/gold

    Case report 06 May 2023 Pages: 15 - 15

16. Acetazolamide/antiglaucomas

    Case report 06 May 2023 Pages: 16 - 16

17. Aciclovir/mycophenolate mofetil/valaciclovir interactions

    Case report 06 May 2023 Pages: 17 - 17

18. Acitretin

    Case report 06 May 2023 Pages: 18 - 18

19. Aconitum-carmichaeli

    Case report 06 May 2023 Pages: 19 - 19

20. Ad26.COV2-S

    Case report 06 May 2023 Pages: 20 - 20

21. Adalimumab

    Case report 06 May 2023 Pages: 21 - 21

22. Adalimumab

    Case report 06 May 2023 Pages: 22 - 22

23. Adalimumab/azathioprine/mesalazine

    Case report 06 May 2023 Pages: 23 - 23

24. Amenamevir

    Case report 06 May 2023 Pages: 24 - 24

25. Amoxicillin/lamotrigine

    Case report 06 May 2023 Pages: 25 - 25

26. Amphotericin-B/isavuconazonium

    Case report 06 May 2023 Pages: 26 - 26

27. Analgesics/morphine

    Case report 06 May 2023 Pages: 27 - 27

28. Analgesics/morphine overdose

    Case report 06 May 2023 Pages: 28 - 28

29. Antibacterials

    Case report 06 May 2023 Pages: 29 - 29

30. Antibacterials

    Case report 06 May 2023 Pages: 30 - 30

31. Antibacterials/antineoplastics

    Case report 06 May 2023 Pages: 31 - 31

32. Antibacterials/warfarin interaction

    Case report 06 May 2023 Pages: 32 - 32

33. Antiepileptic-drugs

    Case report 06 May 2023 Pages: 33 - 33

34. Antihyperglycaemics

    Case report 06 May 2023 Pages: 34 - 34

35. Antihyperglycaemics/lamivudine

    Case report 06 May 2023 Pages: 35 - 35

36. Antineoplastics

    Case report 06 May 2023 Pages: 36 - 36

37. Antineoplastics

    Case report 06 May 2023 Pages: 37 - 37

38. Antineoplastics

    Case report 06 May 2023 Pages: 38 - 38

39. Antineoplastics

    Case report 06 May 2023 Pages: 39 - 39

40. Antineoplastics

    Case report 06 May 2023 Pages: 40 - 40

41. Antineoplastics

    Case report 06 May 2023 Pages: 41 - 41

42. Antineoplastics

    Case report 06 May 2023 Pages: 42 - 42

43. Antineoplastics

    Case report 06 May 2023 Pages: 43 - 43

44. Antineoplastics

    Case report 06 May 2023 Pages: 44 - 44

45. Antineoplastics

    Case report 06 May 2023 Pages: 45 - 45

46. Antineoplastics

    Case report 06 May 2023 Pages: 46 - 46

47. Antineoplastics

    Case report 06 May 2023 Pages: 47 - 47

48. Antineoplastics

    Case report 06 May 2023 Pages: 48 - 48

49. Antineoplastics

    Case report 06 May 2023 Pages: 49 - 49

50. Antineoplastics

    Case report 06 May 2023 Pages: 50 - 50